INCR - intercure.co Company Long-Term Liabilities

Brandmark of intercure.co (INCR)

This price chart for InterCure Ltd. (INCR), which specializes in psychotropic drugs, captures the 0.02 metric. Current quotes are pressured by Middle Eastern logistics issues and slow progress in European legislation. Stable demand for treatment offsets moderate cyclicality, although inflation impacts revenue. Meanwhile, military conflicts in the region of operation pose real threats to infrastructure and block product exports.

InterCure Ltd. (INCR) Company Long-Term Liabilities: for the period 07/04/2022 - 10/29/2026

InterCure (INCR) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart InterCure Ltd|INCR - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation InterCure|INCR - Total Company Value
- shareholders' equity book value data:
Net Asset Value per Share InterCure|INCR - Company Net Assets|Market Value to Book Value intercure.co|INCR - Company Total Assets
- debt level and financial liquidity data:
Aggregate Debt to Equity InterCure Ltd.|INCR - Long-Term Debt to Capital|Short-Term Debt to Capital InterCure Ltd|INCR - Company Debts|Debt to Net Assets Ratio InterCure|INCR - Company Long-Term Debt|Company Current Liabilities InterCure|Interim Coverage Ratio intercure.co
Analysis of all company metrics:InterCure Ltd.
Finished products of InterCure

Long-term debt measures the total liabilities with a maturity of more than one year, where an increase in this indicator signals rising credit risk and potential pressure from interest expenses on net income. By analyzing the level of the business's long-term borrowed capital, an investor can assess the financial stability of InterCure Ltd. (INCR) during the scaling of its pharmacy network and the expansion of medical cannabis across European markets.

Competitors of InterCure Ltd. (INCR)

Company Long-Term Loans and Borrowings INDV|Collegium Pharmaceutical, Inc. - Company Long-Term Debts|Cronos Group Inc (CRON) - Company Long-Term Liabilities|Tweed (CGC) - Company Long-Term Debt|Long-Term Debt Canna Cabana (HITI)|Company Long-Term Liabilities ACB|ACHV: Company Long-Term Loans and Borrowings|Company Long-Term Debts SKYE|ANEB: Long-Term Liabilities|Company Long-Term Debts NTRB (Nutriband)|Company Long-Term Debts Nasus Pharma Ltd. NSRX|IGC - Company Long-Term Debt|Company Long-Term Loans and Borrowings MIRA (MIRA Pharmaceuticals)|Flora Growth (FLGC) - Company Long-Term Debt|Company Long-Term Liabilities IM Cannabis|ADIL (Adial Pharmaceuticals Inc.) - Company Long-Term Debts|Artelo (ARTL) - Long-Term Debt Volume|Company Long-Term Debt Ensysce Biosciences (ENSC)|titanpharm.com - Company Long-Term Indebtedness|Greenlane - Company Long-Term Liabilities|Amount of Long-Term Liabilities INM (InMed Pharmaceuticals Inc)|Akanda Corporation - Company Long-Term Debts|Long-Term Debt Enveric Corp|brightgreen.us (BGXX) - Company Long-Term Debt|hempaccoinc.com - Company Long-Term Loans and Borrowings